Funded Grants

The V Foundation’s grant making model ensures the most promising cancer research projects at state-of-the-art facilities around the country are funded. Cancer research grants are awarded to innovative researchers with the most cutting-edge ideas on how to improve cancer diagnosis methods, prevent cancer recurrences or defeat cancer. 100% of direct donations are used to fund projects we identify as the most likely to help those diagnosed with cancer.

2017
Guido Marcucci, M.D.
Immunotherapeutic targeting of IL-1-RAP to eliminate leukemia stem cells (LSC) in Acute...
Read More
2017
Kimberly Kirkwood, M.D.
Minimally Invasive Classification of Pancreatic Cystic Neoplasms
Read More
2017
Manuel Hidalgo, Ph.D., M.D.
Autologous Dendritic Cell Vaccine for Pancreatic Cancer
Read More
2017
Alejandro Gutierrez, M.D.
JAK3 Inhibition as a Therapeutic Strategy to Reverse Chemotherapy Resistance
Read More
2017
Timothy Graubert, M.D.
ATR Inhibition as a Therapeutic Strategy for Spliceosomal-Mutant Leukemia
Read More
2017
Lucy Godley, Ph.D., M.D.
Identifying inherited variants that predispose to lymphoid malignancies
Read More
2017
Todd Fehniger, Ph.D., M.D.
Translating NK cell memory into cancer immunotherapy clinical trials
Read More
2017
Michael Engel, M.D., Ph.D.
Pre-clinical and Phase 1 clinical testing of the LSD1 inhibitor, SP-2577 in...
Read More
2017
Michael Deininger, Ph.D., M.D. & Thomas O’Hare, Ph.D.
Targeting SIRT5 in acute myeloid leukemia
Read More
2017
Vered Stearns, M.D. & Roisin Connolly, M.D.
Harnessing the Immune System to Treat Breast Cancer
Read More
2016
Bradley Bernstein, M.D., Ph.D. and John Mullen, M.D.
Liposarcoma Genome Project
Read More
2016
Jessica Blackburn, Ph.D.
Single cell characterization and targeting of leukemia stem cells to prevent Acute...
Read More
2016
Anupriya Agarwal, M.S., Ph.D.
Critical role of microenvironment-driven interleukin-√ in AML disease progression and T cell...
Read More
2016
James Alvarez, Ph.D.
Targeting Dormant Cell Metabolism to Prevent Metastatic Recurrence
Read More
2016
Justin M. Balko, Pharm.D., Ph.D.
Maximizing neo-antigens in cancer by epigenetic modulation: improving responses to immunotherapy
Read More
2016
Raymond Blind, Ph.D.
Nuclear lipids as hepatocellular carcinoma biomarkers.
Read More